Replies to post #15776 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

The super soft sugarcoated version:

I take no pleasure in anyone's belief Algernon has enough money on hand to trip through multiple Phase 1 clinical trials before needing cash.

Please break down the amount of cash on hand and the cost of all clinical trials thus far loosely projected to start in 2022:

DMT Stroke, Small Cell Lung Cancer, Pancreatic Cancer. Chronic Kidney Disease, and whatever other pie in the sky Moreau adds to the cake batter in 2022.

Sir, are you aware of the fact Algernon filed an SEC Form 1 on 2-22-2022? If so. do you understand it was filed to issue new shares on the Nasdaq as soon as possible?

What I suggest anyone still confused about the situation at hand is call Beer Buddy and ask him directly what's up with the SEC filings. Surely, he can further explain the financing plan as written in the filings.

Sir, the facts you dispute are written in a relatively EZ to understand black and white format/font here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167963800

OAN: NJV you get no rebuttal from me.

M$